- Home
- HCAT
HCAT
Health Catalyst Inc
as 01-21-2025 4:00pm EST
Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platforms, analytics applications, and support services. This generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.
| Founded: | 2008 | Country: | United States |
| Employees: | N/A | City: | SOUTH JORDAN |
| Market Cap: | 334.1M | IPO Year: | 2019 |
| Target Price: | $10.91 | AVG Volume (30 days): | 732.9K |
| Analyst Decision: | Buy | Number of Analysts: | 11 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.34 | EPS Growth: | N/A |
| 52 Week Low/High: | $5.35 - $10.99 | Next Earning Date: | 02-20-2025 |
| Revenue: | $302,062,000 | Revenue Growth: | 4.15% |
| Revenue Growth (this year): | 5.83% | Revenue Growth (next year): | 10.50% |
Stock Insider Trading Activity of Health Catalyst Inc (HCAT)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Gallagher Duncan | HCAT | Director | Dec 30 '24 | Sell | $6.93 | 4,500 | $31,184.10 | 69,938 | |
| Gallagher Duncan | HCAT | Director | Dec 23 '24 | Sell | $6.98 | 4,500 | $31,415.40 | 69,938 | |
| Llewelyn Linda | HCAT | Chief People Officer | Dec 16 '24 | Sell | $7.88 | 6,442 | $50,793.88 | 98,702 | |
| Alger Jason | HCAT | Chief Financial Officer | Dec 6 '24 | Sell | $8.32 | 19,599 | $163,049.96 | 86,712 | |
| Landry Benjamin | HCAT | General Counsel | Dec 6 '24 | Sell | $8.32 | 19,268 | $160,294.35 | 72,250 | |
| LeSueur Daniel | HCAT | Chief Operating Officer | Dec 4 '24 | Sell | $7.70 | 22,773 | $175,242.79 | 96,462 | |
| Freeman Kevin Lee | HCAT | Chief Commercial Officer | Dec 1 '24 | Sell | $8.94 | 7,500 | $67,073.25 | 236,950 | |
| Llewelyn Linda | HCAT | Chief People Officer | Nov 15 '24 | Sell | $8.50 | 1,365 | $11,602.50 | 98,702 | |
| LeSueur Daniel | HCAT | Chief Operating Officer | Nov 5 '24 | Sell | $7.70 | 5,209 | $40,127.01 | 96,462 |
Latest Health Catalyst Inc News
HCAT Breaking Stock News: Dive into HCAT Ticker-Specific Updates for Smart Investing
MT Newswires
7 days ago
RBC Cuts Price Target on Health Catalyst to $7 From $9, Keeps Sector Perform Rating
TipRanks
8 days ago
Health Catalyst to Acquire Upfront Healthcare Services
MT Newswires
9 days ago
Health Catalyst to Buy Upfront Healthcare Services
PR Newswire
9 days ago
OrthoNebraska Selects Health Catalyst Ignite™ to Advance Data-Driven Orthopedic Care
PR Newswire
9 days ago
Health Catalyst Partners with Databricks to Elevate Next-Gen Healthcare Data Sharing and Analytics
PR Newswire
9 days ago
Health Catalyst Recognized as a Leader in Frost & Sullivan's 2024 US Population Health Management Report
PR Newswire
9 days ago
Health Catalyst Signs Definitive Agreement to Acquire Upfront Healthcare Services
Simply Wall St.
a month ago
Shareholders in Health Catalyst (NASDAQ:HCAT) are in the red if they invested three years ago
Compare HCAT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "HCAT Health Catalyst Inc - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.